- Home
- CUE vs IOR Comparison
CUE vs IOR Comparison
Compare CUE & IOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- IOR
- Stock Information
- Founded
- CUE 2014
- IOR 1984
- Country
- CUE United States
- IOR United States
- Employees
- CUE N/A
- IOR N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- IOR Real Estate Investment Trusts
- Sector
- CUE Health Care
- IOR Real Estate
- Exchange
- CUE Nasdaq
- IOR Nasdaq
- Market Cap
- CUE 64.4M
- IOR 68.6M
- IPO Year
- CUE 2018
- IOR N/A
- Fundamental
- Price
- CUE $1.25
- IOR $17.00
- Analyst Decision
- CUE Strong Buy
- IOR
- Analyst Count
- CUE 5
- IOR 0
- Target Price
- CUE $5.00
- IOR N/A
- AVG Volume (30 Days)
- CUE 971.4K
- IOR 758.0
- Earning Date
- CUE 11-14-2024
- IOR 11-07-2024
- Dividend Yield
- CUE N/A
- IOR N/A
- EPS Growth
- CUE N/A
- IOR 5.45
- EPS
- CUE N/A
- IOR 1.47
- Revenue
- CUE $9,532,000.00
- IOR N/A
- Revenue This Year
- CUE $104.81
- IOR N/A
- Revenue Next Year
- CUE N/A
- IOR N/A
- P/E Ratio
- CUE N/A
- IOR $11.59
- Revenue Growth
- CUE 149.53
- IOR N/A
- 52 Week Low
- CUE $0.45
- IOR $11.66
- 52 Week High
- CUE $3.25
- IOR $19.00
- Technical
- Relative Strength Index (RSI)
- CUE 43.10
- IOR 53.33
- Support Level
- CUE $1.32
- IOR $16.50
- Resistance Level
- CUE $1.99
- IOR $17.14
- Average True Range (ATR)
- CUE 0.29
- IOR 0.14
- MACD
- CUE -0.06
- IOR 0.03
- Stochastic Oscillator
- CUE 0.67
- IOR 70.42
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.
About IOR Income Opportunity Realty Investors Inc.
Income Opportunity Realty Investors Inc is a U.S.-based company that is an externally managed company that invests in mortgage notes receivables and real property. Its business is managed by Pillar Income Asset Management, Inc. Pillar's duties include, but are not limited to, locating, evaluating and recommending real estate and real estate-related investment opportunities. Pillar also arranges its debt and equity financing with unaffiliated independent third party lenders and investors.